Arno Mohr

Dr. Arno Mohr

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 February 2021 in Multidisciplinary Respiratory Medicine
Verified
Journal Article
Open access
PDF file
AMArno Mohr
Arno Mohr
LDLaura Dannerbeck
Laura Dannerbeck
TLTobias J. Lange
Tobias J. Lange
MPMichael Pfeifer
Michael Pfeifer
SBStefan Blaas
Stefan Blaas
MKMyriam Koch
Myriam Koch
Cause and mechanisms of persistent dyspnoea after recovery from COVID-19 are not well described. The objective is to describe causal factors for persistent dyspnoea in patients after COVID-19. We examined patients reporting dyspnoea after recovery from COVID-19 by cardiopulmonary exercise testing. After exclusion of patients with pre-existing lung diseases, ten patients (mean age 50±13.1 years) were retrospectively analysed between May 14th and September 15th, 2020. On chest computed tomography, five patients showed residual ground glass opacities, and one patient showed streaky residua. A slight reduction of the mean diffusion capacity of the lung for carbon monoxide was noted in the cohort. Mean peak oxygen uptake was reduced with 1512±232 ml/min (72.7% predicted), while mean peakwork rate was preserved with 131±29 W (92.4% predicted). Mean alveolar-arterial oxygen gradient (AaDO2) at peak exercise was 25.6±11.8 mmHg. Mean value of lactate post exercise was 5.6±1.8 mmol/l. A gap between peak work rate in (92.4% predicted) to peak oxygen uptake (72.3% pred.) was detected in our study cohort. Mean value of lactate post exercise was high in our study population and even higher (n.s.) compared to the subgroup of patients with reduced peak oxygen uptake and other obvious reason for limitation. Both observations support the hypothesis of anaerobic metabolism. The main reason for dyspnoea may therefore be muscular.

12 February 2020 in Infection
Verified
Journal Article
Closed access
PDF file
AMArno Mohr
Arno Mohr
MSMichaela Simon
Michaela Simon
TJTobias Joha
Tobias Joha
FHFrank Hanses
Frank Hanses
BSBernd Salzberger
Bernd Salzberger
FHFlorian Hitzenbichler
Florian Hitzenbichler

1 November 2020 in Respiratory Medicine
Verified
Journal Article
Closed access
AMArno Mohr
Arno Mohr
APAnnelie Plentz
Annelie Plentz
ASAnna Sieroslawski
Anna Sieroslawski
FPFabian Pezenburg
Fabian Pezenburg
MPMichael Pfeifer
Michael Pfeifer
FHFlorian Hitzenbichler
Florian Hitzenbichler

16 February 2022 in Vaccines
Verified
Journal Article
Open access
PDF file
AMArno Mohr
Arno Mohr
MKMia Kloos
Mia Kloos
CSChristian Schulz
Christian Schulz
MPMichael Pfeifer
Michael Pfeifer
BSBernd Salzberger
Bernd Salzberger
MKMyriam Koch
Myriam Koch
Introduction: The aim of this study was to investigate the adherence to vaccinations, especially pneumococcal vaccinations, in lung cancer patients. Methods: the study was performed at the University Hospital Regensburg, Germany. All patients with a regular appointment scheduled between 1 December 2020 and 29 April 2021 and who provided informed consent were included. Available medical records, vaccination certificates, and a questionnaire were analyzed. Results: we included 136 lung cancer patients (NSCLC n = 113, 83.1%, SCLC n = 23, 16.9%). A correct pneumococcal vaccination according to national recommendations was performed in 9.4% (12/127) of the patients. A correct vaccination was performed for tetanus in 50.4% (66/131), diphtheria in 34.4% (44/128), poliomyelitis in 25.8% (33/128), tick-borne encephalitis in 40.7% (24/59), hepatitis A in 45.5% (7/11), hepatitis B in 38.5% (5/13), shingles in 3.0% (3/101), measles in 50.0% (3/6), pertussis in 47.7% (62/130), influenza in 54.4% (74/136), and meningococcal meningitis in 0% (0/2) of the patients. Conclusion: adherence to pneumococcal vaccinations, as well as to other vaccinations, is low in lung cancer patients.

7 October 2021 in Infection
Verified
Journal Article
Closed access
PDF file
AMArno Mohr
Arno Mohr
APAnnelie Plentz
Annelie Plentz
ASAnna Sieroslawski
Anna Sieroslawski
FPFabian Pezenburg
Fabian Pezenburg
MKMyriam Koch
Myriam Koch
FHFlorian Hitzenbichler
Florian Hitzenbichler

25 November 2019 in Laryngo-Rhino-Otologie
Verified
Journal Article
Closed access
PDF file
CHConstantin A. Hintschich
Constantin A. Hintschich
VVVeronika Vielsmeier
Veronika Vielsmeier
AMArno Mohr
Arno Mohr
CBChristopher Bohr
Christopher Bohr
Eine junge, aus Eritrea stammende und im 9. Monat schwangere Patientin (35 + 2 SSW bei Aufnahme) stellte sich in unserer Poliklinik mit einer progredienten retropharyngealen Schwellung und Odynophagie vor. Aufgrund der Sprachbarriere war die Anamnese nur durch einen telefonisch übersetzenden Bekannten zu erheben. Sie habe seit 2 bis 3 Monaten Halsschmerzen und neuerdings auch Rückenschmerzen. Inzwischen hätte sie etwas Gewicht verloren. Husten, Fieber und Nachtschweiß wurden verneint. Die Schwangerschaft verlief laut des mitgeführten Mutterpasses normal.